$SSSS
SURO CAPITAL CORP. Stock $ssss

$ssss Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000149315224009905 Filed on March 14, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	-$3.223M	-$2.744M	-$13.44M
YoY Change	-23.66%	-4.16%	-8.62%
Cost Of Revenue	$1.214M	$1.215M	$4.858M
YoY Change	0.08%	0.0%	0.26%
Gross Profit	$313.8K	$1.244M	$1.739M
YoY Change	265.8%	402.41%	-225.15%
Gross Profit Margin
Selling, General & Admin	$3.087M	$3.688M	$13.36M
YoY Change	-19.14%	34.11%	13.96%
% of Gross Profit	983.71%	296.35%	768.11%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$4.751M	$5.204M	$20.04M
YoY Change	-13.94%	20.29%	10.31%
Operating Profit	-$4.437M	-$3.959M	-$18.30M
YoY Change	-18.36%	-2.92%	-6.42%
Interest Expense	$1.214M	-$6.379M	$4.858M
YoY Change	0.08%	-33.05%	0.26%
% of Operating Profit
Other Income/Expense, Net	$449.6K		$1.823M
YoY Change	-8.17%		14.01%
Pretax Income	-$22.07M	-$9.123M	$5.067M
YoY Change	-577.97%	-26.38%	-103.83%
Income Tax	$2.100K		$624.0K
% Of Pretax Income			12.32%
Net Earnings	-$22.07M	-$9.123M	$5.067M
YoY Change	-577.97%	-26.38%	-103.83%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.87	-$0.36	$0.19
Diluted Earnings Per Share	-$0.87	-$0.36	$0.19
COMMON SHARES
Basic Shares Outstanding	25.35M shares	25.21M shares	26.22M shares
Diluted Shares Outstanding	25.39M shares	25.25M shares	26.22M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$50.81M	$28.18M	$28.18M
YoY Change	5.61%	-29.76%	-29.76%
Cash & Equivalents	$50.81M	$28.18M
Short-Term Investments
Other Short-Term Assets	$467.2K	$494.6K	$494.6K
YoY Change	-28.59%	-31.97%	-31.97%
Inventory
Prepaid Expenses
Receivables	$137.7K	$132.6K	$132.6K
Other Receivables	$236.3K	$309.3K	$309.3K
Total Short-Term Assets	$51.66M	$29.11M	$29.11M
YoY Change	4.39%	-30.03%	-30.03%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$204.6M	$247.9M	$247.9M
YoY Change	-15.11%	2.33%	2.33%
Other Assets	$577.9K	$594.7K	$594.7K
YoY Change	7.19%	7.01%	7.01%
Total Long-Term Assets	$205.2M	$248.5M	$248.5M
YoY Change	-15.06%	2.34%	2.34%
TOTAL ASSETS
Total Short-Term Assets	$51.66M	$29.11M	$29.11M
Total Long-Term Assets	$205.2M	$248.5M	$248.5M
Total Assets	$256.9M	$277.6M	$277.6M
YoY Change	-11.76%	-2.39%	-2.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.271M	$346.3K	$346.3K
YoY Change	-46.83%	-51.14%	-51.14%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.315M	$498.8K	$498.8K
YoY Change	-48.98%	-50.37%	-50.37%
LONG-TERM LIABILITIES
Long-Term Debt	$73.83M	$73.75M	$73.75M
YoY Change	0.49%	0.49%	0.49%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$73.83M	$73.75M	$73.75M
YoY Change	0.49%	0.49%	0.49%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.315M	$498.8K	$498.8K
Total Long-Term Liabilities	$73.83M	$73.75M	$73.75M
Total Liabilities	$75.15M	$74.24M	$74.24M
YoY Change	-1.19%	-0.2%	-0.2%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$253.5K	$254.5K
YoY Change	-10.53%	-10.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$181.7M	$203.4M	$203.4M
YoY Change
Total Liabilities & Shareholders Equity	$256.9M	$277.6M	$277.6M
YoY Change	-11.76%	-2.39%	-2.39%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$22.07M	-$9.123M	$5.067M
YoY Change	-577.97%	-26.38%	-103.83%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$22.74M	-$45.29M	$2.383M
YoY Change	180.65%	-8830.43%	-102.16%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid	$107.8K		$143.7K
YoY Change	0.0%		-99.46%
Common Stock Issuance & Retirement, Net			$14.18M
YoY Change			-33.19%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$107.8K	-35.83K	-$14.32M
YoY Change	0.0%	-33.35%	-70.01%
NET CHANGE
Cash From Operating Activities	$22.74M	-45.29M	$2.383M
Cash From Investing Activities
Cash From Financing Activities	-$107.8K	-35.83K	-$14.32M
Net Change In Cash	$22.64M	-45.32M	-$11.94M
YoY Change	183.09%	-9847.5%	-92.46%
FREE CASH FLOW
Cash From Operating Activities	$22.74M	-$45.29M	$2.383M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.40
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30023202	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26758367	shares
CY2023	SSSS	Investment Company Dividend Declared InvestmentCompanyDividendDeclared		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001509470
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssets
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssets
CY2023Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
CY2022Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
CY2023	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution		usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2023	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend		usd
CY2022	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend		usd
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue		usd
CY2023	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues		shares
CY2023	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities		shares
CY2022	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities		shares
CY2023	us-gaap	Stock Dividends Shares StockDividendsShares		shares
CY2022	us-gaap	Stock Dividends Shares StockDividendsShares		shares
CY2021	SSSS	Stock Repurchased For Capital Share Activity StockRepurchasedForCapitalShareActivity		shares
CY2023	SSSS	Amortization Of Convertible Senior Debt Discount AmortizationOfConvertibleSeniorDebtDiscount		usd
CY2022	SSSS	Amortization Of Convertible Senior Debt Discount AmortizationOfConvertibleSeniorDebtDiscount		usd
CY2022	SSSS	Accrued Interest On Us Treasury Bills AccruedInterestOnUSTreasuryBills		usd
CY2021	SSSS	Accrued Interest On Us Treasury Bills AccruedInterestOnUSTreasuryBills		usd
CY2023	SSSS	Forfeited Interest On Convertible Senior Notes ForfeitedInterestOnConvertibleSeniorNotes		usd
CY2022	SSSS	Forfeited Interest On Convertible Senior Notes ForfeitedInterestOnConvertibleSeniorNotes		usd
CY2021	SSSS	Purchases Of Us Treasury Bills Investments PurchasesOfUSTreasuryBillsInvestments		usd
CY2023	SSSS	Increase Decrease In Proceeds Receivable IncreaseDecreaseInProceedsReceivable		usd
CY2023	SSSS	Increase Decrease In Payable For Securities Purchased IncreaseDecreaseInPayableForSecuritiesPurchased		usd
CY2022	SSSS	Increase Decrease In Payable For Securities Purchased IncreaseDecreaseInPayableForSecuritiesPurchased		usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable		usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable		usd
CY2023	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet		usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023	SSSS	Proceeds From Issuance ProceedsFromIssuance		usd
CY2022	SSSS	Proceeds From Issuance ProceedsFromIssuance		usd
CY2023	SSSS	Repayments Of Redemption Of Convertible Senior Notes RepaymentsOfRedemptionOfConvertibleSeniorNotes		usd
CY2022	SSSS	Repayments Of Redemption Of Convertible Senior Notes RepaymentsOfRedemptionOfConvertibleSeniorNotes		usd
CY2023	SSSS	Payments Of Deferred Debt Issuance Costs PaymentsOfDeferredDebtIssuanceCosts		usd
CY2022	SSSS	Payments Of Deferred Debt Issuance Costs PaymentsOfDeferredDebtIssuanceCosts		usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2023	SSSS	Cash Paid For Fractional Shares CashPaidForFractionalShares		usd
CY2022	SSSS	Cash Paid For Fractional Shares CashPaidForFractionalShares		usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
CY2023	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1		usd
CY2022	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1		usd
CY2023	SSSS	Adjustment For Dilutive Effect AdjustmentForDilutiveEffect		usd
CY2022	SSSS	Adjustment For Dilutive Effect AdjustmentForDilutiveEffect		usd
CY2023	SSSS	Investment Company Unrealized Investment Income Loss Provision For Taxes On Unrealized Appreciation Of Investments InvestmentCompanyUnrealizedInvestmentIncomeLossProvisionForTaxesOnUnrealizedAppreciationOfInvestments
CY2022	SSSS	Investment Company Unrealized Investment Income Loss Provision For Taxes On Unrealized Appreciation Of Investments InvestmentCompanyUnrealizedInvestmentIncomeLossProvisionForTaxesOnUnrealizedAppreciationOfInvestments
CY2021	SSSS	Investment Company Unrealized Investment Income Loss Provision For Taxes On Unrealized Appreciation Of Investments InvestmentCompanyUnrealizedInvestmentIncomeLossProvisionForTaxesOnUnrealizedAppreciationOfInvestments
CY2020	SSSS	Investment Company Unrealized Investment Income Loss Provision For Taxes On Unrealized Appreciation Of Investments InvestmentCompanyUnrealizedInvestmentIncomeLossProvisionForTaxesOnUnrealizedAppreciationOfInvestments
CY2023	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare
CY2023	SSSS	Investment Company Issuance Of Common Stock From Stock Dividend InvestmentCompanyIssuanceOfCommonStockFromStockDividend
CY2022	SSSS	Investment Company Issuance Of Common Stock From Stock Dividend InvestmentCompanyIssuanceOfCommonStockFromStockDividend
CY2020	SSSS	Investment Company Issuance Of Common Stock From Stock Dividend InvestmentCompanyIssuanceOfCommonStockFromStockDividend
CY2019	SSSS	Investment Company Issuance Of Common Stock From Stock Dividend InvestmentCompanyIssuanceOfCommonStockFromStockDividend
CY2023	SSSS	Investment Company Issuance Offering Per Share InvestmentCompanyIssuanceOfferingPerShare
CY2019	SSSS	Investment Company Issuance Offering Per Share InvestmentCompanyIssuanceOfferingPerShare
CY2023	SSSS	Investment Company Conversion Unit Per Share InvestmentCompanyConversionUnitPerShare
CY2022	SSSS	Investment Company Conversion Unit Per Share InvestmentCompanyConversionUnitPerShare
CY2019	SSSS	Investment Company Conversion Unit Per Share InvestmentCompanyConversionUnitPerShare
CY2021	SSSS	Investment Company Repurchase Per Share InvestmentCompanyRepurchasePerShare
CY2023	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio		pure
CY2022	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio		pure
CY2021	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio		pure
CY2020	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio		pure
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
CY2023	SSSS	Investment Company Ordinary Income InvestmentCompanyOrdinaryIncome		usd
CY2022	SSSS	Investment Company Ordinary Income InvestmentCompanyOrdinaryIncome		usd
CY2021	SSSS	Investment Company Ordinary Income InvestmentCompanyOrdinaryIncome		usd
CY2023	SSSS	Long Term Capital Gain LongTermCapitalGain		usd
CY2023	us-gaap	Investment Company Tax Return Of Capital Distribution InvestmentCompanyTaxReturnOfCapitalDistribution		usd
CY2022	us-gaap	Investment Company Tax Return Of Capital Distribution InvestmentCompanyTaxReturnOfCapitalDistribution		usd
CY2021	us-gaap	Investment Company Tax Return Of Capital Distribution InvestmentCompanyTaxReturnOfCapitalDistribution		usd
CY2023	SSSS	Investment Company Investment Income Net InvestmentCompanyInvestmentIncomeNet		usd
CY2022	SSSS	Investment Company Investment Income Net InvestmentCompanyInvestmentIncomeNet		usd
CY2021	SSSS	Investment Company Investment Income Net InvestmentCompanyInvestmentIncomeNet		usd
CY2023Q4	us-gaap	Investment Company Distributable Earnings Loss Accumulated Ordinary Income Loss InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	814-00852
CY2023	dei	Entity Registrant Name EntityRegistrantName	SuRo Capital Corp.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-4443543
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	640 Fifth Avenue
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	12th Floor
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10019
CY2023	dei	City Area Code CityAreaCode	(212)
CY2023	dei	Local Phone Number LocalPhoneNumber	931-6331
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	77250963	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	25353284	shares
CY2023	dei	Auditor Firm AuditorFirmId	688
CY2023	dei	Auditor Name AuditorName	Marcum LLP
CY2023	dei	Auditor Location AuditorLocation	San Francisco, CA
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	184081249	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	157188578	usd
CY2023Q4	SSSS	Investments In U.S.Treasury Bills Cost InvestmentsInU.s.TreasuryBillsCost	63810855	usd
CY2022Q4	SSSS	Investments In U.S.Treasury Bills Cost InvestmentsInU.s.TreasuryBillsCost	85056817	usd
CY2023Q4	us-gaap	Investments Investments	247892104	usd
CY2022Q4	us-gaap	Investments Investments	242245395	usd
CY2023Q4	us-gaap	Cash Cash	28178352	usd
CY2022Q4	us-gaap	Cash Cash	40117598	usd
CY2023Q4	SSSS	Escrow Proceeds Receivable EscrowProceedsReceivable	309293	usd
CY2022Q4	SSSS	Escrow Proceeds Receivable EscrowProceedsReceivable	628332	usd
CY2023Q4	SSSS	Interest And Dividends Receivable InterestAndDividendsReceivable	132607	usd
CY2022Q4	SSSS	Interest And Dividends Receivable InterestAndDividendsReceivable	138766	usd
CY2023Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	594726	usd
CY2022Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	555761	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	494602	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	727006	usd
CY2023Q4	us-gaap	Assets Assets	277601684	usd
CY2022Q4	us-gaap	Assets Assets	284412858	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	346308	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	708827	usd
CY2023Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	152523	usd
CY2022Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	296170	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	73745207	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	73387159	usd
CY2023Q4	us-gaap	Liabilities Liabilities	74244038	usd
CY2022Q4	us-gaap	Liabilities Liabilities	74392156	usd
CY2023Q4	us-gaap	Assets Net AssetsNet	203357646	usd
CY2022Q4	us-gaap	Assets Net AssetsNet	210020702	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	25445805	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25445805	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	28429499	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	28429499	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	254458	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	284295	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	248454107	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	330899254	usd
CY2023Q4	SSSS	Accumulated Net Investment Loss AccumulatedNetInvestmentLoss	-4304111	usd
CY2022Q4	SSSS	Accumulated Net Investment Loss AccumulatedNetInvestmentLoss	-64832605	usd
CY2023Q4	SSSS	Accumulated Net Realized Gain On Investments Net Of Distributions AccumulatedNetRealizedGainOnInvestmentsNetOfDistributions	-12348772	usd
CY2022Q4	SSSS	Accumulated Net Realized Gain On Investments Net Of Distributions AccumulatedNetRealizedGainOnInvestmentsNetOfDistributions	2552465	usd
CY2023Q4	SSSS	Accumulated Net Unrealized Depreciation Appreciation Of Investments AccumulatedNetUnrealizedDepreciationAppreciationOfInvestments	-28698036	usd
CY2022Q4	SSSS	Accumulated Net Unrealized Depreciation Appreciation Of Investments AccumulatedNetUnrealizedDepreciationAppreciationOfInvestments	-58882707	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	203357646	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	210020702	usd
CY2023Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	7.99
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	7.39
CY2023Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0600	pure
CY2023	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2026-12-30
CY2023Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0600	pure
CY2023Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0653	pure
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	75000000	usd
CY2022Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0600	pure
CY2022Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0653	pure
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	75000000	usd
CY2023	us-gaap	Investment Income Net InvestmentIncomeNet	6596780	usd
CY2022	us-gaap	Investment Income Net InvestmentIncomeNet	3456193	usd
CY2021	us-gaap	Investment Income Net InvestmentIncomeNet	1470842	usd
CY2023	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	9482867	usd
CY2022	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	7566452	usd
CY2021	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	6162716	usd
CY2023	SSSS	Directors Fees DirectorsFees	645548	usd
CY2022	SSSS	Directors Fees DirectorsFees	675716	usd
CY2021	SSSS	Directors Fees DirectorsFees	752442	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	2602894	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	3395260	usd
CY2021	us-gaap	Professional Fees ProfessionalFees	2665689	usd
CY2023	us-gaap	Interest Expense InterestExpense	4858049	usd
CY2022	us-gaap	Interest Expense InterestExpense	4845549	usd
CY2021	us-gaap	Interest Expense InterestExpense	693526	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	624049	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	82238	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9347	usd
CY2023	us-gaap	Other Expenses OtherExpenses	1822982	usd
CY2022	us-gaap	Other Expenses OtherExpenses	1598986	usd
CY2021	us-gaap	Other Expenses OtherExpenses	1117941	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	20036389	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	18164201	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	11401661	usd
CY2023	us-gaap	Net Investment Income NetInvestmentIncome	-13439609	usd
CY2022	us-gaap	Net Investment Income NetInvestmentIncome	-14708008	usd
CY2021	us-gaap	Net Investment Income NetInvestmentIncome	-9930819	usd
CY2023	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-11947504	usd
CY2022	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-5905453	usd
CY2021	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	218735504	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	30453935	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-111563592	usd
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-61732964	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	5066822	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-132177053	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	147071721	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.40
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.69
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.19
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5.52
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26222667	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30023202	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25861642	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26222667	shares
CY2023	us-gaap	Net Investment Income NetInvestmentIncome	-13439609	usd
CY2022	us-gaap	Net Investment Income NetInvestmentIncome	-14708008	usd
CY2021	us-gaap	Net Investment Income NetInvestmentIncome	-9930819	usd
CY2023	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-11947504	usd
CY2022	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-5905453	usd
CY2021	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	218735504	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	30453935	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-111563592	usd
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-61732964	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	5066822	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-132177053	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	147071721	usd
CY2022	SSSS	Investment Company Dividend Declared InvestmentCompanyDividendDeclared	3441824	usd
CY2021	SSSS	Investment Company Dividend Declared InvestmentCompanyDividendDeclared	212197025	usd
CY2022	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	3441824	usd
CY2021	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	212197025	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	229896	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	78608	usd
CY2023	SSSS	Stock Issued During Period Values Share Based Compensation Gross StockIssuedDuringPeriodValuesShareBasedCompensationGross	2448807	usd
CY2022	SSSS	Stock Issued During Period Values Share Based Compensation Gross StockIssuedDuringPeriodValuesShareBasedCompensationGross	2015600	usd
CY2021	SSSS	Stock Issued During Period Values Share Based Compensation Gross StockIssuedDuringPeriodValuesShareBasedCompensationGross	1306615	usd
CY2023	us-gaap	Debt Instrument Convertible Conversion Ratio1 DebtInstrumentConvertibleConversionRatio1	0.0475	pure
CY2022	us-gaap	Debt Instrument Convertible Conversion Ratio1 DebtInstrumentConvertibleConversionRatio1	0.0475	pure
CY2021	us-gaap	Debt Instrument Convertible Conversion Ratio1 DebtInstrumentConvertibleConversionRatio1	0.0475	pure
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	37259819	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	89743813	usd
CY2023	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	14178685	usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	21452541	usd
CY2023	SSSS	Investment Company Capital Share Transactions InvestmentCompanyCapitalShareTransactions	-11729878	usd
CY2022	SSSS	Investment Company Capital Share Transactions InvestmentCompanyCapitalShareTransactions	-19207045	usd
CY2021	SSSS	Investment Company Capital Share Transactions InvestmentCompanyCapitalShareTransactions	128388855	usd
CY2023	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	-6663056	usd
CY2022	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	-154825922	usd
CY2021	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	63263551	usd
CY2022Q4	us-gaap	Assets Net AssetsNet	210020702	usd
CY2021Q4	us-gaap	Assets Net AssetsNet	364846624	usd
CY2020Q4	us-gaap	Assets Net AssetsNet	301583073	usd
CY2023Q4	us-gaap	Assets Net AssetsNet	203357646	usd
CY2022Q4	us-gaap	Assets Net AssetsNet	210020702	usd
CY2021Q4	us-gaap	Assets Net AssetsNet	364846624	usd
CY2022Q4	us-gaap	Shares Outstanding SharesOutstanding	28429499	shares
CY2021Q4	us-gaap	Shares Outstanding SharesOutstanding	31118556	shares
CY2020Q4	us-gaap	Shares Outstanding SharesOutstanding	19914023	shares
CY2022	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	17807	shares
CY2021	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	5900	shares
CY2023	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	202799	shares
CY2022	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	301812	shares
CY2021	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	369298	shares
CY2023	us-gaap	Debt Instrument Convertible Conversion Ratio1 DebtInstrumentConvertibleConversionRatio1	0.0475	pure
CY2022	us-gaap	Debt Instrument Convertible Conversion Ratio1 DebtInstrumentConvertibleConversionRatio1	0.0475	pure
CY2021	us-gaap	Debt Instrument Convertible Conversion Ratio1 DebtInstrumentConvertibleConversionRatio1	0.0475	pure
CY2021	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	4097808	shares
CY2021	us-gaap	Stock Dividends Shares StockDividendsShares	6731527	shares
CY2023	SSSS	Stock Repurchased For Capital Share Activity StockRepurchasedForCapitalShareActivity	-3186493	shares
CY2022	SSSS	Stock Repurchased For Capital Share Activity StockRepurchasedForCapitalShareActivity	-3008676	shares
CY2023Q4	us-gaap	Shares Outstanding SharesOutstanding	25445805	shares
CY2022Q4	us-gaap	Shares Outstanding SharesOutstanding	28429499	shares
CY2021Q4	us-gaap	Shares Outstanding SharesOutstanding	31118556	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	5066822	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-132177053	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	147071721	usd
CY2023	SSSS	Realized Investment Gain Losses RealizedInvestmentGainLosses	-11947504	usd
CY2022	SSSS	Realized Investment Gain Losses RealizedInvestmentGainLosses	-5905453	usd
CY2021	SSSS	Realized Investment Gain Losses RealizedInvestmentGainLosses	218735504	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	30453935	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-111563592	usd
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-61732964	usd
CY2021	SSSS	Amortization Of Convertible Senior Debt Discount AmortizationOfConvertibleSeniorDebtDiscount	76927	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	319092	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	425550	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	16310	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	2448807	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2015600	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	1306615	usd
CY2023	SSSS	Adjustments To Escrow Proceeds Receivable AdjustmentsToEscrowProceedsReceivable	117136	usd
CY2022	SSSS	Adjustments To Escrow Proceeds Receivable AdjustmentsToEscrowProceedsReceivable	-859121	usd
CY2021	SSSS	Adjustments To Escrow Proceeds Receivable AdjustmentsToEscrowProceedsReceivable	1934622	usd
CY2023	SSSS	Accrued Interest On Us Treasury Bills AccruedInterestOnUSTreasuryBills	-13024	usd
CY2021	SSSS	Forfeited Interest On Convertible Senior Notes ForfeitedInterestOnConvertibleSeniorNotes	102917	usd
CY2023	SSSS	Purchases Of Portfolio Investments PurchasesOfPortfolioInvestments	24485431	usd
CY2022	SSSS	Purchases Of Portfolio Investments PurchasesOfPortfolioInvestments	22783388	usd
CY2021	SSSS	Purchases Of Portfolio Investments PurchasesOfPortfolioInvestments	81716039	usd
CY2023	SSSS	Purchases Of Us Treasury Bills Investments PurchasesOfUSTreasuryBillsInvestments	253585717	usd
CY2022	SSSS	Purchases Of Us Treasury Bills Investments PurchasesOfUSTreasuryBillsInvestments	184172673	usd
CY2023	SSSS	Proceeds From Sales Or Maturity Of Investments Portfolio Investments ProceedsFromSalesOrMaturityOfInvestmentsPortfolioInvestments	16008100	usd
CY2022	SSSS	Proceeds From Sales Or Maturity Of Investments Portfolio Investments ProceedsFromSalesOrMaturityOfInvestmentsPortfolioInvestments	9063919	usd
CY2021	SSSS	Proceeds From Sales Or Maturity Of Investments Portfolio Investments ProceedsFromSalesOrMaturityOfInvestmentsPortfolioInvestments	257427478	usd
CY2023	SSSS	Proceeds From Sales Or Maturity Of Investments Us Treasury Bills ProceedsFromSalesOrMaturityOfInvestmentsUSTreasuryBills	274792611	usd
CY2022	SSSS	Proceeds From Sales Or Maturity Of Investments Us Treasury Bills ProceedsFromSalesOrMaturityOfInvestmentsUSTreasuryBills	99173075	usd
CY2021	SSSS	Proceeds From Sales Or Maturity Of Investments Us Treasury Bills ProceedsFromSalesOrMaturityOfInvestmentsUSTreasuryBills	150000000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-232404	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-210978	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-47566	usd
CY2023	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	-6159	usd
CY2022	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	55111	usd
CY2021	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	-83343	usd
CY2022	SSSS	Increase Decrease In Proceeds Receivable IncreaseDecreaseInProceedsReceivable	-52493	usd
CY2021	SSSS	Increase Decrease In Proceeds Receivable IncreaseDecreaseInProceedsReceivable	52493	usd
CY2023	SSSS	Increase Decrease In Escrow Proceeds Receivable IncreaseDecreaseInEscrowProceedsReceivable	-319039	usd
CY2022	SSSS	Increase Decrease In Escrow Proceeds Receivable IncreaseDecreaseInEscrowProceedsReceivable	-1418313	usd
CY2021	SSSS	Increase Decrease In Escrow Proceeds Receivable IncreaseDecreaseInEscrowProceedsReceivable	1194183	usd
CY2021	SSSS	Increase Decrease In Payable For Securities Purchased IncreaseDecreaseInPayableForSecuritiesPurchased	-134250000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-362519	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-166220	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	112735	usd
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-35850	usd
CY2022	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-175000	usd
CY2021	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-278803	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2383096	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-110559593	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	183650326	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	229896	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	78608	usd
CY2021	SSSS	Proceeds From Issuance ProceedsFromIssuance	75000000	usd
CY2021	SSSS	Repayments Of Redemption Of Convertible Senior Notes RepaymentsOfRedemptionOfConvertibleSeniorNotes	290000	usd
CY2021	SSSS	Payments Of Deferred Debt Issuance Costs PaymentsOfDeferredDebtIssuanceCosts	1970892	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	14178685	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	21452541	usd
CY2023	us-gaap	Payments Of Dividends PaymentsOfDividends	143657	usd
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	26535702	usd
CY2021	us-gaap	Payments Of Dividends PaymentsOfDividends	103458098	usd
CY2021	SSSS	Cash Paid For Fractional Shares CashPaidForFractionalShares	399	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1540	usd
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	366191	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-14322342	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-47759887	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-31006972	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-11939246	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-158319480	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	152643354	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	40117598	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	198437078	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	45793724	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	28178352	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	40117598	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	198437078	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	4500000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	4662500	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	794206	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	533894	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	82238	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	43499	usd
CY2021	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	37925000	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80B_eus-gaap--NatureOfOperations_zNa9Wv2MELql" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1—<span id="xdx_82C_zOAHxuD3WAi">NATURE OF OPERATIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SuRo Capital Corp. (“we”, “us”, “our”, “Company” or “SuRo Capital”), formerly known as Sutter Rock Capital Corp. and as GSV Capital Corp. and formed in September 2010 as a Maryland corporation, is an internally managed, non-diversified closed-end management investment company. The Company has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”), and has elected to be treated, and intends to qualify annually, as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s date of inception was January 6, 2011, which is the date it commenced development stage activities. The Company’s common stock is currently listed on the Nasdaq Global Select Market under the symbol “SSSS” (formerly “GSVC”). Prior to November 24, 2021, the Company’s common stock traded on the Nasdaq Capital Market under the same symbol (“SSSS”). The Company began its investment operations during the second quarter of 2011.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below displays the Company’s subsidiaries as of December 31, 2023, which, other than GSV Capital Lending, LLC (“GCL”) and SuRo Capital Sports, LLC, are collectively referred to as the “Taxable Subsidiaries.” The Taxable Subsidiaries were formed to hold certain portfolio investments. The Taxable Subsidiaries, including their associated portfolio investments, are consolidated with the Company for accounting purposes, but have elected to be treated as separate entities for U.S. federal income tax purposes. GCL was formed to originate portfolio loan investments within the state of California and is consolidated with the Company for accounting purposes. Refer to “Note 2—Significant Accounting Policies—<i>Basis of Consolidation</i>” below for further detail.</span></p> <p id="xdx_896_ecustom--ScheduleOfSubsidiariesOfCompanyTableTextBlock_zfbtoChnD5Id" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B6_zjXBkGuQPYRl" style="display: none">SCHEDULE OF COMPANY’S SUBSIDIARIES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span id="ex_001"></span>Subsidiary</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Jurisdiction of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incorporation</b></span></p></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Formation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></p></td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Owned</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%">GCL</td><td style="width: 2%"> </td> <td style="width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--EntityIncorporationStateCountryCode_c20230101__20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GCLMember_z69YrADhx2Rh" title="Jurisdiction of Incorporation">Delaware</span></span></td><td style="width: 2%; text-align: left"> </td> <td id="xdx_986_edei--EntityIncorporationDateOfIncorporation_c20230101__20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GCLMember_zxjeApsiTtV2" style="width: 20%; text-align: center" title="Formation Date">April 13, 2012</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_c20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GCLMember_zwtG705OYXS9" style="width: 16%; text-align: right" title="Percentage Owned">100</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">SuRo Capital Sports, LLC (“SuRo Sports”)</td><td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--EntityIncorporationStateCountryCode_c20230101__20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SuRoCapitalSportsLLCSuRoSportsMember_zTv8hfKSn4t7" title="Jurisdiction of Incorporation">Delaware</span></span></td><td style="text-align: left"> </td> <td id="xdx_98D_edei--EntityIncorporationDateOfIncorporation_c20230101__20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SuRoCapitalSportsLLCSuRoSportsMember_zIcYcEi6a5z8" style="text-align: center" title="Formation Date">March 19, 2021</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_c20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--SuRoCapitalSportsLLCSuRoSportsMember_zJGAtJ5Z86L7" style="text-align: right" title="Percentage Owned">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Subsidiaries below are referred to collectively as the “Taxable Subsidiaries”</td><td> </td> <td style="text-align: center"> </td><td style="text-align: left"> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">GSVC AE Holdings, Inc. (“GAE”)</td><td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--EntityIncorporationStateCountryCode_c20230101__20231231__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAEHoldingsIncGAEMember_zLDIQzCf3kN9" title="Jurisdiction of Incorporation">Delaware</span></span></td><td style="text-align: left"> </td> <td id="xdx_98E_edei--EntityIncorporationDateOfIncorporation_c20230101__20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAEHoldingsIncGAEMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zrC4zrBu4W5h" style="text-align: center" title="Formation Date">November 28, 2012</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_c20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAEHoldingsIncGAEMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_z2zxXdmIX408" style="text-align: right" title="Percentage Owned">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">GSVC AV Holdings, Inc. (“GAV”)</td><td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--EntityIncorporationStateCountryCode_c20230101__20231231__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAVHoldingsIncGAVMember_z87GDVpSQIi8" title="Jurisdiction of Incorporation">Delaware</span></span></td><td style="text-align: left"> </td> <td id="xdx_98A_edei--EntityIncorporationDateOfIncorporation_c20230101__20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAVHoldingsIncGAVMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zs3uoygF3F4l" style="text-align: center" title="Formation Date">November 28, 2012</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_c20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCAVHoldingsIncGAVMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zAhkTAUnvs7c" style="text-align: right" title="Percentage Owned">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">GSVC SW Holdings, Inc. (“GSW”)</td><td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--EntityIncorporationStateCountryCode_c20230101__20231231__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSWHoldingsIncGSWMember_zWIukKCHpTsb" title="Jurisdiction of Incorporation">Delaware</span></span></td><td style="text-align: left"> </td> <td id="xdx_982_edei--EntityIncorporationDateOfIncorporation_c20230101__20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSWHoldingsIncGSWMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zuuHyZQoMVwf" style="text-align: center" title="Formation Date">November 28, 2012</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSWHoldingsIncGSWMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_z5CSZuJMXKIc" style="text-align: right" title="Percentage Owned">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">GSVC SVDS Holdings, Inc. (“SVDS”)</td><td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--EntityIncorporationStateCountryCode_c20230101__20231231__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSVDSHoldingsIncSVDSMember_zEC0XpotDFGa" title="Jurisdiction of Incorporation">Delaware</span></span></td><td style="text-align: left"> </td> <td id="xdx_986_edei--EntityIncorporationDateOfIncorporation_c20230101__20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSVDSHoldingsIncSVDSMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zr32OhQGcnuc" style="text-align: center" title="Formation Date">August 13, 2013</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--GSVCSVDSHoldingsIncSVDSMember__srt--ConsolidatedEntitiesAxis__custom--TaxableSubsidiariesMember_zmlyVP5Q8J15" style="text-align: right" title="Percentage Owned">100</td><td style="text-align: left">%</td></tr> </table> <p id="xdx_8AC_zEm1mjJLPbp4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s investment objective is to maximize its portfolio’s total return, principally by seeking capital gains on its equity and equity-related investments, and to a lesser extent, income from debt investments. The Company invests principally in the equity securities of what it believes to be rapidly growing venture capital-backed emerging companies. The Company may invest in these portfolio companies through offerings of the prospective portfolio companies, transactions on secondary marketplaces for private companies, or negotiations with selling stockholders. In addition, the Company may invest in private credit and in founders equity, founders warrants, forward purchase agreements, and private investment in public equity transactions of special purpose acquisition companies (“SPACs”). The Company may also invest on an opportunistic basis in select publicly traded equity securities or certain non-U.S. companies that otherwise meet its investment criteria, subject to any applicable limitations under the 1940 Act.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SURO CAPITAL CORP. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_zMqRfxv2mfg5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zXSriYDTOCHi">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of Consolidated Financial Statements in accordance with GAAP requires the Company’s management to make a number of significant estimates. These include estimates of the fair value of certain assets and liabilities and other estimates that affect the reported amounts of certain assets and liabilities as of the date of the Consolidated Financial Statements and the reported amounts of certain revenues and expenses during the reporting period. It is likely that changes in these estimates may occur in the near term. The Company’s estimates are inherently subjective in nature and actual results could differ materially from such estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2023Q4	SSSS	Escrow Proceeds Receivable EscrowProceedsReceivable	309293	usd
CY2022Q4	SSSS	Escrow Proceeds Receivable EscrowProceedsReceivable	628332	usd
CY2023Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	594726	usd
CY2022Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	555761	usd
CY2019Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P5Y
CY2023Q4	us-gaap	Escrow Deposit EscrowDeposit	0	usd
CY2022Q4	us-gaap	Escrow Deposit EscrowDeposit	0	usd
CY2023Q4	SSSS	Number Of Positions NumberOfPositions	63
CY2023Q4	SSSS	Number Of Portfolio Companies NumberOfPortfolioCompanies	38
CY2022Q4	SSSS	Number Of Positions NumberOfPositions	64
CY2022Q4	SSSS	Number Of Portfolio Companies NumberOfPortfolioCompanies	39
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	184081249	usd
CY2023Q4	SSSS	Investment Owned Percent Of Investment Portfolio InvestmentOwnedPercentOfInvestmentPortfolio	1.000	pure
CY2023Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.906	pure
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	157188578	usd
CY2022Q4	SSSS	Investment Owned Percent Of Investment Portfolio InvestmentOwnedPercentOfInvestmentPortfolio	1.000	pure
CY2022Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.748	pure
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	184081249	usd
CY2023Q4	SSSS	Investment Owned Percent Of Investment Portfolio InvestmentOwnedPercentOfInvestmentPortfolio	1.000	pure
CY2023Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.906	pure
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	157188578	usd
CY2022Q4	SSSS	Investment Owned Percent Of Investment Portfolio InvestmentOwnedPercentOfInvestmentPortfolio	1.000	pure
CY2022Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.748	pure
CY2023Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	247892104	usd
CY2022Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	242245395	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	143865093	usd
CY2023	SSSS	Transfers Transfers	-2711842	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	24485430	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-1374302	usd
CY2023	SSSS	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Exercises And Conversions FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisExercisesAndConversions	30820	usd
CY2023	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-9815023	usd
CY2023	SSSS	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain And Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainAndLoss	14088075	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	168568251	usd
CY2023	SSSS	Fair Value Asset Recurring Basis Still Held Unrealized Gain And Loss Oci FairValueAssetRecurringBasisStillHeldUnrealizedGainAndLossOci	3136307	usd
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	214632504	usd
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	214632504	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	8742396	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	22780064	usd
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-1874470	usd
CY2022	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	90586	usd
CY2022	SSSS	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain And Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainAndLoss	-83021195	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	143865093	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	143865093	usd
CY2022	SSSS	Fair Value Asset Recurring Basis Still Held Unrealized Gain And Loss Oci FairValueAssetRecurringBasisStillHeldUnrealizedGainAndLossOci	-70818192	usd
CY2023Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	60000000.0	usd
CY2023	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	186493	shares
CY2022	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	1008676	shares
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	5066822	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-132177053	usd
CY2021	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	147071721	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26222667	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30023202	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25861642	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.40
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.69
CY2023	SSSS	Income Loss From Continuing Operations Diluted IncomeLossFromContinuingOperationsDiluted	5066822	usd
CY2022	SSSS	Income Loss From Continuing Operations Diluted IncomeLossFromContinuingOperationsDiluted	-132177053	usd
CY2021	SSSS	Income Loss From Continuing Operations Diluted IncomeLossFromContinuingOperationsDiluted	147071721	usd
CY2021	SSSS	Adjustment For Interest And Amortization AdjustmentForInterestAndAmortization	501065	usd
CY2023	SSSS	Net Change In Net Assets Resulting From Operations As Adjusted Diluted NetChangeInNetAssetsResultingFromOperationsAsAdjustedDiluted	5066822	usd
CY2022	SSSS	Net Change In Net Assets Resulting From Operations As Adjusted Diluted NetChangeInNetAssetsResultingFromOperationsAsAdjustedDiluted	-132177053	usd
CY2021	SSSS	Net Change In Net Assets Resulting From Operations As Adjusted Diluted NetChangeInNetAssetsResultingFromOperationsAsAdjustedDiluted	147572786	usd
CY2021	SSSS	Adjustment For Dilutive Effect AdjustmentForDilutiveEffect	896725	usd
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26222667	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30023202	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26758367	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.19
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.40
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5.52
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	112485	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	112485	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	288268	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	288268	usd
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	16574	usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	16574	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	204109	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	192176	usd
CY2023Q4	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P0Y7M6D
CY2023Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0300	pure
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	113603	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	113603	usd
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	7.39
CY2021Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	11.72
CY2020Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	15.14
CY2019Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	11.38
CY2018Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	9.89
CY2023	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	-0.51
CY2022	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	-0.49
CY2021	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	-0.38
CY2020	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	-0.81
CY2019	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	-0.49
CY2023	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	-0.46
CY2022	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	-0.20
CY2021	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	8.46
CY2020	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.92
CY2019	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.99
CY2023	SSSS	Investment Company Unrealized Investment Income Loss From Operations Per Share InvestmentCompanyUnrealizedInvestmentIncomeLossFromOperationsPerShare	1.16
CY2022	SSSS	Investment Company Unrealized Investment Income Loss From Operations Per Share InvestmentCompanyUnrealizedInvestmentIncomeLossFromOperationsPerShare	-3.72
CY2021	SSSS	Investment Company Unrealized Investment Income Loss From Operations Per Share InvestmentCompanyUnrealizedInvestmentIncomeLossFromOperationsPerShare	-2.39
CY2020	SSSS	Investment Company Unrealized Investment Income Loss From Operations Per Share InvestmentCompanyUnrealizedInvestmentIncomeLossFromOperationsPerShare	3.78
CY2019	SSSS	Investment Company Unrealized Investment Income Loss From Operations Per Share InvestmentCompanyUnrealizedInvestmentIncomeLossFromOperationsPerShare	0.69
CY2019	SSSS	Investment Company Unrealized Investment Income Loss Provision For Taxes On Unrealized Appreciation Of Investments InvestmentCompanyUnrealizedInvestmentIncomeLossProvisionForTaxesOnUnrealizedAppreciationOfInvestments	-0.05
CY2022	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.11
CY2021	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	8.00
CY2020	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.87
CY2019	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.32
CY2021	SSSS	Investment Company Issuance Of Common Stock From Stock Dividend InvestmentCompanyIssuanceOfCommonStockFromStockDividend	-0.74
CY2022	SSSS	Investment Company Issuance Offering Per Share InvestmentCompanyIssuanceOfferingPerShare	0.01
CY2021	SSSS	Investment Company Issuance Offering Per Share InvestmentCompanyIssuanceOfferingPerShare	0.01
CY2020	SSSS	Investment Company Issuance Offering Per Share InvestmentCompanyIssuanceOfferingPerShare	0.30
CY2021	SSSS	Investment Company Conversion Unit Per Share InvestmentCompanyConversionUnitPerShare	-1.91
CY2020	SSSS	Investment Company Conversion Unit Per Share InvestmentCompanyConversionUnitPerShare	-0.11
CY2023	SSSS	Investment Company Repurchase Per Share InvestmentCompanyRepurchasePerShare	0.32
CY2022	SSSS	Investment Company Repurchase Per Share InvestmentCompanyRepurchasePerShare	0.11
CY2020	SSSS	Investment Company Repurchase Per Share InvestmentCompanyRepurchasePerShare	0.43
CY2019	SSSS	Investment Company Repurchase Per Share InvestmentCompanyRepurchasePerShare	0.52
CY2023	SSSS	Investment Company Share Based Compensation Arrangement By Share Based Payment InvestmentCompanyShareBasedCompensationArrangementByShareBasedPayment	0.09
CY2022	SSSS	Investment Company Share Based Compensation Arrangement By Share Based Payment InvestmentCompanyShareBasedCompensationArrangementByShareBasedPayment	0.07
CY2021	SSSS	Investment Company Share Based Compensation Arrangement By Share Based Payment InvestmentCompanyShareBasedCompensationArrangementByShareBasedPayment	0.05
CY2020	SSSS	Investment Company Share Based Compensation Arrangement By Share Based Payment InvestmentCompanyShareBasedCompensationArrangementByShareBasedPayment	0.12
CY2019	SSSS	Investment Company Share Based Compensation Arrangement By Share Based Payment InvestmentCompanyShareBasedCompensationArrangementByShareBasedPayment	0.05
CY2023Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	7.99
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	7.39
CY2021Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	11.72
CY2020Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	15.14
CY2019Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	11.38
CY2023Q4	SSSS	Market Value Value Per Share MarketValueValuePerShare	3.94
CY2022Q4	SSSS	Market Value Value Per Share MarketValueValuePerShare	3.80
CY2021Q4	SSSS	Market Value Value Per Share MarketValueValuePerShare	12.95
CY2020Q4	SSSS	Market Value Value Per Share MarketValueValuePerShare	13.09
CY2019Q4	SSSS	Market Value Value Per Share MarketValueValuePerShare	6.55
CY2023	SSSS	Investment Company Total Return Basedon Market Value InvestmentCompanyTotalReturnBasedonMarketValue	0.0368	pure
CY2022	SSSS	Investment Company Total Return Basedon Market Value InvestmentCompanyTotalReturnBasedonMarketValue	-0.6945	pure
CY2021	SSSS	Investment Company Total Return Basedon Market Value InvestmentCompanyTotalReturnBasedonMarketValue	0.6005	pure
CY2020	SSSS	Investment Company Total Return Basedon Market Value InvestmentCompanyTotalReturnBasedonMarketValue	0.9985	pure
CY2019	SSSS	Investment Company Total Return Basedon Market Value InvestmentCompanyTotalReturnBasedonMarketValue	0.3161	pure
CY2023	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.0812	pure
CY2022	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	-0.3601	pure
CY2021	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.3025	pure
CY2020	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.3304	pure
CY2019	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.1508	pure
CY2023Q4	us-gaap	Shares Outstanding SharesOutstanding	25445805	shares
CY2022Q4	us-gaap	Shares Outstanding SharesOutstanding	28429499	shares
CY2021Q4	us-gaap	Shares Outstanding SharesOutstanding	31118556	shares
CY2020Q4	us-gaap	Shares Outstanding SharesOutstanding	19914023	shares
CY2019Q4	us-gaap	Shares Outstanding SharesOutstanding	17564244	shares
CY2023Q4	us-gaap	Assets Net AssetsNet	203357646	usd
CY2022Q4	us-gaap	Assets Net AssetsNet	210020702	usd
CY2021Q4	us-gaap	Assets Net AssetsNet	364846624	usd
CY2020Q4	us-gaap	Assets Net AssetsNet	301583073	usd
CY2019Q4	us-gaap	Assets Net AssetsNet	199917289	usd
CY2023	SSSS	Average Net Asset AverageNetAsset	207608591	usd
CY2022	SSSS	Average Net Asset AverageNetAsset	310086061	usd
CY2021	SSSS	Average Net Asset AverageNetAsset	396209139	usd
CY2020	SSSS	Average Net Asset AverageNetAsset	205430809	usd
CY2019	SSSS	Average Net Asset AverageNetAsset	209261190	usd
CY2023	us-gaap	Investment Company Expense Ratio Before Incentive Allocation InvestmentCompanyExpenseRatioBeforeIncentiveAllocation	0.0970	pure
CY2022	us-gaap	Investment Company Expense Ratio Before Incentive Allocation InvestmentCompanyExpenseRatioBeforeIncentiveAllocation	0.0587	pure
CY2021	us-gaap	Investment Company Expense Ratio Before Incentive Allocation InvestmentCompanyExpenseRatioBeforeIncentiveAllocation	0.0288	pure
CY2020	us-gaap	Investment Company Expense Ratio Before Incentive Allocation InvestmentCompanyExpenseRatioBeforeIncentiveAllocation	0.0795	pure
CY2019	us-gaap	Investment Company Expense Ratio Before Incentive Allocation InvestmentCompanyExpenseRatioBeforeIncentiveAllocation	0.0608	pure
CY2019	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	-0.42	pure
CY2023	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.0970	pure
CY2022	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.0587	pure
CY2021	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.0288	pure
CY2020	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.0795	pure
CY2019	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.0566	pure
CY2023	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	-0.0651	pure
CY2022	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	-0.0476	pure
CY2021	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	-0.0251	pure
CY2020	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	-0.0707	pure
CY2019	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	-0.0452	pure
CY2023	SSSS	Investment Company Turnover Ratio After Incentive Allocation InvestmentCompanyTurnoverRatioAfterIncentiveAllocation	0.0934	pure
CY2022	SSSS	Investment Company Turnover Ratio After Incentive Allocation InvestmentCompanyTurnoverRatioAfterIncentiveAllocation	0.0431	pure
CY2021	SSSS	Investment Company Turnover Ratio After Incentive Allocation InvestmentCompanyTurnoverRatioAfterIncentiveAllocation	0.2834	pure
CY2020	SSSS	Investment Company Turnover Ratio After Incentive Allocation InvestmentCompanyTurnoverRatioAfterIncentiveAllocation	0.1487	pure
CY2019	SSSS	Investment Company Turnover Ratio After Incentive Allocation InvestmentCompanyTurnoverRatioAfterIncentiveAllocation	0.1295	pure
CY2021	SSSS	Non Recurring Expense NonRecurringExpense	100274	usd
CY2020	SSSS	Non Recurring Expense NonRecurringExpense	1962431	usd
CY2019	SSSS	Non Recurring Expense NonRecurringExpense	1769820	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.04	pure
CY2023	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	(1) 98% of its ordinary income (taking into account certain deferrals and elections) for each calendar year, (2) 98.2% of its capital gain net income (adjusted for certain ordinary losses) for the 1-year period ending October 31 of each such calendar year and (3) any ordinary income and net capital gains for preceding years, but not distributed during such years and on which the Company paid no U.S. federal income tax
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.04	pure
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	usd
CY2023	SSSS	Capital In Excess Of Par Value CapitalInExcessOfParValue	-70745103	usd
CY2022	SSSS	Capital In Excess Of Par Value CapitalInExcessOfParValue	-14709928	usd
CY2023	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	73968102	usd
CY2022	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	14709928	usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	-2953733	usd
CY2023Q4	us-gaap	Investment Income Net InvestmentIncomeNet	2459734	usd
CY2023Q3	us-gaap	Investment Income Net InvestmentIncomeNet	1465746	usd
CY2022	SSSS	Long Term Capital Gain LongTermCapitalGain	3441824	usd
CY2021	SSSS	Long Term Capital Gain LongTermCapitalGain	212197026	usd
CY2023Q4	us-gaap	Tax Basis Of Investments Cost For Income Tax Purposes TaxBasisOfInvestmentsCostForIncomeTaxPurposes	268353952	usd
CY2022Q4	us-gaap	Tax Basis Of Investments Cost For Income Tax Purposes TaxBasisOfInvestmentsCostForIncomeTaxPurposes	294674345	usd
CY2023Q4	us-gaap	Tax Basis Of Investments Gross Unrealized Appreciation TaxBasisOfInvestmentsGrossUnrealizedAppreciation	73341574	usd
CY2023Q4	us-gaap	Tax Basis Of Investments Gross Unrealized Depreciation TaxBasisOfInvestmentsGrossUnrealizedDepreciation	93803419	usd
CY2022Q4	us-gaap	Tax Basis Of Investments Gross Unrealized Appreciation TaxBasisOfInvestmentsGrossUnrealizedAppreciation	56250562	usd
CY2022Q4	us-gaap	Tax Basis Of Investments Gross Unrealized Depreciation TaxBasisOfInvestmentsGrossUnrealizedDepreciation	108679513	usd
CY2023Q4	us-gaap	Tax Basis Of Investments Unrealized Appreciation Depreciation Net TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet	20461845	usd
CY2022Q4	us-gaap	Tax Basis Of Investments Unrealized Appreciation Depreciation Net TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet	52428951	usd
CY2022Q4	us-gaap	Investment Company Distributable Earnings Loss Accumulated Ordinary Income Loss InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss	-45822672	usd
CY2023Q4	us-gaap	Investment Company Distributable Earnings Loss Accumulated Long Term Capital Gain Loss InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss	-20584963	usd
CY2022Q4	us-gaap	Investment Company Distributable Earnings Loss Accumulated Long Term Capital Gain Loss InvestmentCompanyDistributableEarningsLossAccumulatedLongTermCapitalGainLoss	-3901291	usd
CY2023Q4	us-gaap	Investment Company Distributable Earnings Loss Accumulated Appreciation Depreciation InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation	-20461845	usd
CY2022Q4	us-gaap	Investment Company Distributable Earnings Loss Accumulated Appreciation Depreciation InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation	-52428951	usd
CY2023Q4	SSSS	Investments Company Distributable Earnings InvestmentsCompanyDistributableEarnings	-41046808	usd
CY2022Q4	SSSS	Investments Company Distributable Earnings InvestmentsCompanyDistributableEarnings	-102152914	usd
CY2023Q2	us-gaap	Investment Income Net InvestmentIncomeNet	1372218	usd
CY2023Q1	us-gaap	Investment Income Net InvestmentIncomeNet	1299082	usd
CY2023Q4	us-gaap	Operating Expenses OperatingExpenses	5203812	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	4134172	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	5177558	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	5520847	usd
CY2023Q4	us-gaap	Net Investment Income NetInvestmentIncome	-2744078	usd
CY2023Q3	us-gaap	Net Investment Income NetInvestmentIncome	-2668426	usd
CY2023Q2	us-gaap	Net Investment Income NetInvestmentIncome	-3805340	usd
CY2023Q1	us-gaap	Net Investment Income NetInvestmentIncome	-4221765	usd
CY2023Q4	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	2594633	usd
CY2023Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-1461281	usd
CY2023Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-13270199	usd
CY2023Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	189343	usd
CY2023Q4	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-8973578	usd
CY2023Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	29323067	usd
CY2023Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1455515	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	8648931	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-9123023	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	25193360	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-15620024	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	4616509	usd
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.99
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.60
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.16
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.99
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.60
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.16
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25251921	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25351306	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25952447	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28378529	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25251921	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25351306	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25952447	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28378529	shares
CY2022Q4	us-gaap	Investment Income Net InvestmentIncomeNet	1462951	usd
CY2022Q3	us-gaap	Investment Income Net InvestmentIncomeNet	519511	usd
CY2022Q2	us-gaap	Investment Income Net InvestmentIncomeNet	890631	usd
CY2022Q1	us-gaap	Investment Income Net InvestmentIncomeNet	583100	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	4326133	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	4328744	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	4701519	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	4807805	usd
CY2022Q4	us-gaap	Net Investment Income NetInvestmentIncome	-2863182	usd
CY2022Q3	us-gaap	Net Investment Income NetInvestmentIncome	-3809233	usd
CY2022Q2	us-gaap	Net Investment Income NetInvestmentIncome	-3810888	usd
CY2022Q1	us-gaap	Net Investment Income NetInvestmentIncome	-4224705	usd
CY2022Q4	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-1894406	usd
CY2022Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-5141097	usd
CY2022Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-1966225	usd
CY2022Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	3096275	usd
CY2022Q4	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-7633982	usd
CY2022Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-36951920	usd
CY2022Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-88562575	usd
CY2022Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	21584885	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-12391570	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-45902250	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-94339688	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	20456455	usd
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.44
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.54
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.08
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.66
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.44
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.54
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.08
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.66
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28349822	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29781801	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30633878	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31228046	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28349822	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29781801	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30633878	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31228046	shares
CY2021Q4	us-gaap	Investment Income Net InvestmentIncomeNet	380754	usd
CY2021Q3	us-gaap	Investment Income Net InvestmentIncomeNet	523916	usd
CY2021Q2	us-gaap	Investment Income Net InvestmentIncomeNet	274820	usd
CY2021Q1	us-gaap	Investment Income Net InvestmentIncomeNet	291352	usd
CY2021Q4	us-gaap	Operating Expenses OperatingExpenses	3210777	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	2747394	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	2317820	usd
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	3125670	usd
CY2021Q4	us-gaap	Net Investment Income NetInvestmentIncome	-2830023	usd
CY2021Q3	us-gaap	Net Investment Income NetInvestmentIncome	-2223478	usd
CY2021Q2	us-gaap	Net Investment Income NetInvestmentIncome	-2043000	usd
CY2021Q1	us-gaap	Net Investment Income NetInvestmentIncome	-2834318	usd
CY2021Q4	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	46428514	usd
CY2021Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	32495660	usd
CY2021Q2	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	27658812	usd
CY2021Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	112152518	usd
CY2021Q4	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-53134601	usd
CY2021Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-15023778	usd
CY2021Q2	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	7741252	usd
CY2021Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-1315837	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-9536110	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	15248404	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	33357064	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	108002363	usd
CY2021Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.55
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.32
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.27
CY2021Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.55
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.32
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.50
CY2021Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29883824	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27619062	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25334482	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20486621	shares
CY2021Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29883824	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27619062	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25334482	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24123339	shares

Files In Submission

Name	View Source	Status
0001493152-24-009905-index-headers.html	Edgar Link	pending
0001493152-24-009905-index.html	Edgar Link	pending
0001493152-24-009905.txt	Edgar Link	pending
0001493152-24-009905-xbrl.zip	Edgar Link	pending
ex10-14.htm	Edgar Link	pending
ex10-15.htm	Edgar Link	pending
ex14-1.htm	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
ex97-1.htm	Edgar Link	pending
ex97-1_001.jpg	Edgar Link	pending
ex99-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
form10-k_htm.xml	Edgar Link	completed
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ssss-20231231.xsd	Edgar Link	pending
ssss-20231231_def.xml	Edgar Link	unprocessable
ssss-20231231_pre.xml	Edgar Link	unprocessable
ssss-20231231_cal.xml	Edgar Link	unprocessable
ssss-20231231_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SSSS
SURO CAPITAL CORP. Stock $ssss

2024 Q1 Form 10-K Financial Statement

#000149315224009905 Filed on March 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SSSS SURO CAPITAL CORP. Stock $ssss

2024 Q1 Form 10-K Financial Statement

#000149315224009905 Filed on March 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SSSS
SURO CAPITAL CORP. Stock $ssss